Article Text

Download PDFPDF
Severe prolonged gastroparesis after cytoreductive surgery in an advanced ovarian cancer patient
  1. P. Caprino*,
  2. A. Fagotti,
  3. M. Missere,
  4. F. Fanfani and
  5. G. Scambia
  1. *Division of Surgical Oncology, Catholic University of the Sacred Heart, Campobasso, Italy
  2. Gynecologic Oncology, Catholic University of the Sacred Heart, Campobasso, Italy
  3. Radiology, Catholic University of the Sacred Heart, Campobasso, Italy
  1. Address correspondence and reprint requests to: Prof. Giovanni Scambia, MD, Division of Gynecologic Oncology, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy. Email: giovanni.scambia{at}rm.unicatt.it

Abstract

Number and type of complications after ovarian cancer surgery can vary greatly according to both the patient's characteristics, and the extension and type of surgery. Current literature lacks in mentioning specific gastrointestinal side effects, which could be evidenced during the early postoperative course of patients submitted to major gynecological oncologic surgery. A severe gastroparesis prolonged for 2 months after cytoreductive surgery in an advanced ovarian cancer patient was successfully treated with conservative multidrug therapy. Gastroparesis has to be enumerated as a rare but possible event after major gynecological oncologic surgery. A conservative management involving decompressive nasogastric tube, nutritional support, antiemetic drugs, prokinetic drugs is suggested, while surgical therapy is only recommended in a very small subset of unmanageable patients.

  • cytoreduction
  • gastroparesis
  • ovarian cancer

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.